
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| CCJ | +79.72% | +845.72% | +56.73% | +1,385% |
| S&P | +13.96% | +91.24% | +13.85% | +966% |
Cameco Corp. engages in the provision of uranium. It operates through the Uranium and Fuel Services segments. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.
UBS is right about one thing: Cameco stock is too expensive to buy.
The U.S. government is ramping up its investments in nuclear power, which opens up fresh opportunities for companies like Cameco.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $446.20M | -15.5% |
| Gross Profit | $116.42M | 5.2% |
| Gross Margin | 26.09% | 5.1% |
| Market Cap | $36.51B | 75.7% |
| Market Cap / Employee | $12.66M | 0.0% |
| Employees | 2.9K | 9.3% |
| Net Income | -$0.11M | -102.1% |
| EBITDA | $104.25M | -19.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $559.62M | 283.5% |
| Accounts Receivable | $137.20M | -39.3% |
| Inventory | 516.3 | -18.4% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $723.86M | -23.2% |
| Short Term Debt | $0.00M | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 5.44% | 4.2% |
| Return On Invested Capital | 1.19% | 0.2% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $44.49M | 418.0% |
| Operating Free Cash Flow | $112.11M | 268.3% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 181.27 | 101.06 | 84.28 | 96.87 | -60.22% |
| Price to Book | 4.87 | 4.05 | 7.16 | 7.39 | 60.96% |
| Price to Sales | 9.81 | 7.59 | 12.62 | 14.76 | 45.63% |
| Price to Tangible Book Value | 4.90 | 4.07 | 7.21 | 7.43 | 60.78% |
| Price to Free Cash Flow TTM | 58.45 | 44.73 | 58.87 | 60.23 | -47.74% |
| Enterprise Value to EBITDA | 121.51 | 105.43 | 185.98 | 352.17 | 111.11% |
| Free Cash Flow Yield | 1.7% | 2.2% | 1.7% | 1.7% | 91.36% |
| Return on Equity | 2.7% | 3.9% | 8.1% | 8.0% | 325.55% |
| Total Debt | $897.74M | $698.72M | $738.25M | $723.86M | -23.21% |
No podcast episodes available.
CCJ earnings call for the period ending September 30, 2021.
CCJ earnings call for the period ending June 30, 2021.
CCJ earnings call for the period ending March 31, 2021.
CCJ earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.